Veracyte Quarterly Balance Sheet
NASDAQ: VCYTHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Veracyte financial position
As of Jun 30, 2026, Veracyte reported total assets of $1.49 billion, up 10.6% from a year earlier against total liabilities of $98.0 million. Shareholders' equity stood at $1.39 billion, or 93.4% of assets. The company held $299.5 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 9.16, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Veracyte balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 299.52M | 263.14M | 362.58M | 315.57M | 219.50M | 186.12M | 239.09M | 274.08M | 235.91M | 209.19M | 216.45M | 202.46M |
| Short-Term Investments | — | — | 50.31M | — | — | — | — | — | — | — | — | — |
| Receivables | 54.18M | 50.11M | 44.66M | 47.83M | 50.81M | 53.78M | 46.52M | 48.81M | 50.30M | 46.66M | 40.38M | 39.30M |
| Inventory | — | — | 20.55M | 20.33M | 25.02M | 24.25M | 21.75M | 20.36M | 19.26M | 18.33M | 16.13M | 15.89M |
| Total Current Assets | 574.77M | 522.17M | 488.38M | 449.22M | 414.68M | 383.15M | 372.27M | 356.85M | 321.11M | 290.42M | 285.62M | 271.16M |
| Property, Plant & Equipment | 21.93M | 22.65M | 22.19M | 18.90M | 18.55M | 22.53M | 22.95M | 21.19M | 22.29M | 21.57M | 20.58M | 19.29M |
| Goodwill | 767.15M | 767.15M | 767.15M | 767.15M | 773.25M | 754.27M | 745.80M | 762.12M | 752.11M | 753.85M | 702.98M | 693.18M |
| Intangible Assets | 82.70M | 85.86M | 89.15M | 92.48M | 95.81M | 99.09M | 102.30M | 108.87M | 112.53M | 116.35M | 88.59M | 123.57M |
| Total Assets | 1.49B | 1.44B | 1.41B | 1.37B | 1.34B | 1.32B | 1.30B | 1.28B | 1.23B | 1.20B | 1.11B | 1.12B |
| Accounts Payable | 8.02M | 6.91M | 4.59M | 5.51M | 11.45M | 15.71M | 8.63M | 9.67M | 12.08M | 12.15M | 12.94M | 12.53M |
| Total Current Liabilities | 62.74M | 56.12M | 59.94M | 72.15M | 76.43M | 75.13M | 78.63M | 70.31M | 72.34M | 58.05M | 61.24M | 57.26M |
| Total Liabilities | 97.96M | 91.99M | 96.44M | 110.12M | 123.05M | 120.47M | 124.07M | 98.98M | 101.80M | 81.42M | 70.80M | 70.88M |
| Shareholders' Equity | 1.39B | 1.34B | 1.31B | 1.26B | 1.22B | 1.19B | 1.18B | 1.18B | 1.13B | 1.12B | 1.04B | 1.05B |
| Retained Earnings | -323.43M | -348.92M | -377.63M | -418.78M | -437.92M | -436.94M | -443.98M | -449.10M | -464.25M | -469.99M | -468.12M | -439.83M |
| Net Cash (Debt) | 299.52M | 263.14M | 412.89M | 315.57M | 219.50M | 186.12M | 239.09M | 274.08M | 235.91M | 209.19M | 216.45M | 202.46M |
| Shares Outstanding | 80.36M | 79.79M | 79.36M | 79.03M | 78.60M | 78.31M | 77.77M | 77.49M | 76.74M | 76.43M | 73.26M | 72.99M |
This table shows 12 quarterly periods of Veracyte's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow VCYT's reporting calendar. What is a balance sheet?